August’s theme examines how biopharma organizations invite patients and advocates to contribute their time, expertise, and personal experiences. We’ll explore what makes those exchanges equitable—from fair compensation and meaningful influence to greater clarity, continuity, and follow-through—and how communicators can recognize when a patient is being treated as content rather than a collaborator. The theme will establish a shared foundation for deeper-dive resources and programming from the T2B Patient Advocacy & Engagement Roundtable.